162 related articles for article (PubMed ID: 15546508)
1. Non-steroidal anti-inflammatory drugs inhibit cellular proliferation and upregulate cyclooxygenase-2 protein expression in endometrial cancer cells.
Gao J; Niwa K; Sun W; Takemura M; Lian Z; Onogi K; Seishima M; Mori H; Tamaya T
Cancer Sci; 2004 Nov; 95(11):901-7. PubMed ID: 15546508
[TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis by cyclo-oxygenase-2 inhibitor NS398 through a cytochrome C-dependent pathway in esophageal cancer cells.
Li M; Wu X; Xu XC
Int J Cancer; 2001 Jul; 93(2):218-23. PubMed ID: 11410869
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.
Sun Y; Tang XM; Half E; Kuo MT; Sinicrope FA
Cancer Res; 2002 Nov; 62(21):6323-8. PubMed ID: 12414664
[TBL] [Abstract][Full Text] [Related]
4. Induction of apoptosis in colon cancer cells by cyclooxygenase-2 inhibitor NS398 through a cytochrome c-dependent pathway.
Li M; Wu X; Xu XC
Clin Cancer Res; 2001 Apr; 7(4):1010-6. PubMed ID: 11309352
[TBL] [Abstract][Full Text] [Related]
5. Effects of NSAIDs on proliferation of gastric cancer cells in vitro: possible implication of cyclooxygenase-2 in cancer development.
Sawaoka H; Kawano S; Tsuji S; Tsujii M; Murata H; Hori M
J Clin Gastroenterol; 1998; 27 Suppl 1():S47-52. PubMed ID: 9872498
[TBL] [Abstract][Full Text] [Related]
6. Biological Activity of
Kuźmycz O; Kowalczyk A; Stączek P
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232870
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase (COX) inhibitors induce apoptosis in non-small cell lung cancer through cyclooxygenase independent pathways.
Sánchez-Alcázar JA; Bradbury DA; Pang L; Knox AJ
Lung Cancer; 2003 Apr; 40(1):33-44. PubMed ID: 12660005
[TBL] [Abstract][Full Text] [Related]
8. Nimesulide and indomethacin induce apoptosis in head and neck cancer cells.
Pelzmann M; Thurnher D; Gedlicka C; Martinek H; Knerer B
J Oral Pathol Med; 2004 Nov; 33(10):607-13. PubMed ID: 15482327
[TBL] [Abstract][Full Text] [Related]
9. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
[TBL] [Abstract][Full Text] [Related]
10. The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action.
Smith ML; Hawcroft G; Hull MA
Eur J Cancer; 2000 Mar; 36(5):664-74. PubMed ID: 10738133
[TBL] [Abstract][Full Text] [Related]
11. Apo2L/TRAIL differentially modulates the apoptotic effects of sulindac and a COX-2 selective non-steroidal anti-inflammatory agent in Bax-deficient cells.
He Q; Luo X; Huang Y; Sheikh MS
Oncogene; 2002 Sep; 21(39):6032-40. PubMed ID: 12203115
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of COX-2 and induction of apoptosis: two determinants of nonsteroidal anti-inflammatory drugs' chemopreventive efficacies in mouse lung tumorigenesis.
Yao R; Rioux N; Castonguay A; You M
Exp Lung Res; 2000 Dec; 26(8):731-42. PubMed ID: 11195467
[TBL] [Abstract][Full Text] [Related]
13. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis.
Minter HA; Eveson JW; Huntley S; Elder DJ; Hague A
Clin Cancer Res; 2003 May; 9(5):1885-97. PubMed ID: 12738747
[TBL] [Abstract][Full Text] [Related]
14. Significant anti-proliferation of human endometrial cancer cells by combined treatment with a selective COX-2 inhibitor NS398 and specific MEK inhibitor U0126.
Gao J; Niwa K; Takemura M; Sun W; Onogi K; Wu Y; Seishima M; Mori H; Tamaya T
Int J Oncol; 2005 Mar; 26(3):737-44. PubMed ID: 15703831
[TBL] [Abstract][Full Text] [Related]
15. Effects of cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal antiinflammatory drugs on mucosal ulcerogenic and healing responses of the stomach.
Ukawa H; Yamakuni H; Kato S; Takeuchi K
Dig Dis Sci; 1998 Sep; 43(9):2003-11. PubMed ID: 9753266
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of selective COX-2 inhibitors on cell cycle regulation and proliferation of glioblastoma cell lines.
Kardosh A; Blumenthal M; Wang WJ; Chen TC; Schönthal AH
Cancer Biol Ther; 2004 Jan; 3(1):55-62. PubMed ID: 14726653
[TBL] [Abstract][Full Text] [Related]
17. Systematic pharmacological approach to the characterization of NSAIDs.
Lora M; Denault JB; Leduc R; de Brum-Fernandes AJ
Prostaglandins Leukot Essent Fatty Acids; 1998 Jul; 59(1):55-62. PubMed ID: 9758208
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.
Yasumaru M; Tsuji S; Tsujii M; Irie T; Komori M; Kimura A; Nishida T; Kakiuchi Y; Kawai N; Murata H; Horimoto M; Sasaki Y; Hayashi N; Kawano S; Hori M
Cancer Res; 2003 Oct; 63(20):6726-34. PubMed ID: 14583467
[TBL] [Abstract][Full Text] [Related]
19. Nonsteroidal antiinflammatory drugs inhibit cyclooxygenase-2 enzyme activity but not mRNA expression in human macrophages.
Barrios-Rodiles M; Keller K; Belley A; Chadee K
Biochem Biophys Res Commun; 1996 Aug; 225(3):896-900. PubMed ID: 8780708
[TBL] [Abstract][Full Text] [Related]
20. Activation of p53 signalling in acetylsalicylic acid-induced apoptosis in OC2 human oral cancer cells.
Ho CC; Yang XW; Lee TL; Liao PH; Yang SH; Tsai CH; Chou MY
Eur J Clin Invest; 2003 Oct; 33(10):875-82. PubMed ID: 14511359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]